CARLSBAD, Calif., Aug. 30, 2017 -- MaxLinear, Inc. (NYSE:MXL), a leading provider of radio-frequency, mixed-signal and high-performance analog integrated circuits for the connected home, wired and wireless infrastructure, and industrial and multi-market applications announced today that it will attend the following financial conferences.
Financial Conference Schedule
- Roth Capital’s 3rd Annual Data Center and Intelligent Infrastructure Corporate Access Day on Wednesday, September 6, 2017 in San Francisco, CA.
- Deutsche Bank 2017 Technology Conference on Wednesday, September 13, 2017 in Las Vegas, NV.
- A presentation is scheduled for 9:40 AM Pacific Standard Time / 12:40 PM Eastern Standard Time.
- The presentations will be audio webcast, which can be accessed at http://investors.maxlinear.com/. The webcasts will be archived for 90 days following the live presentations.
About MaxLinear, Inc.
MaxLinear, Inc. (NYSE:MXL), a leading provider of radio-frequency, mixed-signal and high-performance analog integrated circuits for the connected home, wired and wireless infrastructure, and industrial and multi-market applications. MaxLinear is headquartered in Carlsbad, California. For more information, please visit www.maxlinear.com.
MXL is MaxLinear’s registered trademark. Other trademarks appearing herein are the property of their respective owners.
MaxLinear, Inc. Investor Relations Contact: Gideon Massey Investor Relations Specialist Tel: 949-333-0056 [email protected]


7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand 



